Literature DB >> 29926236

Various clinicopathological features of patients with metachronous colorectal cancer in relation to different diagnostic intervals.

Po-Yen Lin1, Jy-Ming Chiang2,3,4, Hsin-Yun Huang5,6, Jeng-Fu You5,6, Sum-Fu Chiang5,6, Pao-Shiu Hsieh5,6, Chien-Yuh Yeh5,6, Rei-Ping Tang5,6.   

Abstract

BACKGROUNDS: Clinicopathologic factors relating to developing metachronous colorectal cancer (CRC) have been reported. However, the effects of different diagnostic intervals on these risk factors required further analysis. PATIENTS AND METHODS: This retrospective study comprised 14,481 patients diagnosed from January 1995 to December 2012. Metachronous CRC was defined as the occurrence of a second colorectal cancer at least 1 year post-operatively.
RESULTS: A total of 153 (1.06%) patients developed metachronous CRCs during the follow-up. Significantly higher rates of developing metachronous cancer occurred in male patients (1.2 vs 0.9%), patients with synchronous CRC (2.0 vs 1.0%), and patients with a positive family history of CRC (1.4 vs 0.9%). Pertaining to diagnostic intervals related to clinicopathological features, more severe staging was significant in the diagnostic interval between 2 and 3 years (35 vs 7.7%, 20.6%, 17.5%, P = .01) compared with other intervals. Male patients were more frequently detected to have CRC within 3 years compared with females (53.1 vs 29.1%, P = .005). For a diagnostic interval ≧ 5 years, a significantly higher rate of metachronous CRC located at the right colon was observed than that located at the left colon (36.6 vs 19.7%, p = 0.03).
CONCLUSIONS: We evinced that a diagnostic interval between 2 and 3 years was a key time for metachronous CRC diagnosis with worse staging distribution. Based on current findings, we recommend the stratification of metachronous CRCs into diagnostic intervals of 1-2, 2-3, and ≧ 3 years, as they exhibit significantly different characteristics.

Entities:  

Keywords:  Diagnostic interval; Metachronous CRC

Mesh:

Year:  2018        PMID: 29926236     DOI: 10.1007/s00384-018-3106-7

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  22 in total

1.  Metachronous carcinomas in colorectum and its clinicopathological significance.

Authors:  Alfred King-Yin Lam; Vinod Gopalan; Robert Carmichael; Petra Gertraud Buettner; Melissa Leung; Robert Smith; Cu-Tai Lu; Yik-Hong Ho; Simon Siu
Journal:  Int J Colorectal Dis       Date:  2012-07-25       Impact factor: 2.571

2.  Nomogram prediction of metachronous colorectal neoplasms in patients with colorectal cancer.

Authors:  Kazushige Kawai; Soichiro Ishihara; Hironori Yamaguchi; Eiji Sunami; Joji Kitayama; Hiroaki Miyata; Toshiaki Watanabe
Journal:  Ann Surg       Date:  2015-05       Impact factor: 12.969

3.  Predictive factors for detecting colorectal carcinomas in surveillance colonoscopy after colorectal cancer surgery.

Authors:  K Togashi; F Konishi; A Ozawa; T Sato; K Shito; H Kashiwagi; M Okada; H Nagai
Journal:  Dis Colon Rectum       Date:  2000-10       Impact factor: 4.585

4.  Characteristics of metachronous colorectal carcinoma occurring despite colonoscopic surveillance.

Authors:  B A Leggett; M Cornwell; L R Thomas; R L Buttenshaw; J Searle; J Young; M Ward
Journal:  Dis Colon Rectum       Date:  1997-05       Impact factor: 4.585

5.  The incidence and risk factors of metachronous colorectal cancer: an indication for follow-up.

Authors:  Sanna A Mulder; Ries Kranse; Ronald A Damhuis; Rob J Th Ouwendijk; Ernst J Kuipers; Monique E van Leerdam
Journal:  Dis Colon Rectum       Date:  2012-05       Impact factor: 4.585

6.  Second primary colorectal cancers (SPCRCs): experiences from a large Australian Cancer Registry.

Authors:  C L Ringland; H-T Arkenau; D L O'Connell; R L Ward
Journal:  Ann Oncol       Date:  2009-07-21       Impact factor: 32.976

7.  Clinical characteristics of metachronous colorectal tumors.

Authors:  G Rennert; E Robinson; H S Rennert; A I Neugut
Journal:  Int J Cancer       Date:  1995-03-16       Impact factor: 7.396

8.  Metachronous colorectal cancer: necessity of post-operative colonoscopic surveillance.

Authors:  Yuan-Tzu Lan; Jen-Kou Lin; Anna Fen-Yau Li; Tzu-Chen Lin; Wei-Shone Chen; Jeng-Kae Jiang; Shung-Haur Yang; Huann-Sheng Wang; Shih-Ching Chang
Journal:  Int J Colorectal Dis       Date:  2004-09-02       Impact factor: 2.571

9.  Cumulative incidence of metachronous colorectal cancer.

Authors:  R L Cali; R M Pitsch; A G Thorson; P Watson; P Tapia; G J Blatchford; M A Christensen
Journal:  Dis Colon Rectum       Date:  1993-04       Impact factor: 4.585

10.  Follow-up of patients with colorectal cancer. A meta-analysis.

Authors:  D J Bruinvels; A M Stiggelbout; J Kievit; H C van Houwelingen; J D Habbema; C J van de Velde
Journal:  Ann Surg       Date:  1994-02       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.